BetterLife Pharma Inc.

1275 West 6th Avenue, #300, Vancouver, BC V6H 1A6, CA

Recent News

Pivot Provides Market Activity Update

Vancouver, British Columbia--(Newsfile Corp. - February 13, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), a biopharmaceutical company engaged in the development and commercialization of cannabinoid-based therapeutics using innovative drug formulation and delivery platform technologies, wishes to to address the recent decline in its share price. There has been no material change to Pivot's business plan that would justify the market decline. Pivot...

2018-02-13 3:29 PM EST

Pivot Pharmaceuticals Provides Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - February 12, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), a biopharmaceutical company engaged in the development and commercialization of cannabinoid-based therapeutics using innovative drug formulation and delivery platform technologies, is pleased to provide its shareholders with the following Corporate Update. Pivot has had a very active start to 2018 as the management team continues to build a...

2018-02-12 4:00 AM EST

Pivot Files Three New Provisional Patents for the Delivery of Cannabinoids

Vancouver, British Columbia--(Newsfile Corp. - February 1, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), is pleased to announce that it has filed three provisional patents with the United States Patent and Trademark Office ("USPTO") related to the delivery of cannabinoid-based products. The applications cover the following areas: Transdermal nanotechnology delivery system of cannabis using patches and creams; Mucus topical cannabis delivery system...

2018-02-01 4:00 AM EST

Pivot Continues To Build Technology Portfolio

Vancouver, British Columbia--(Newsfile Corp. - January 17, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), are pleased to provide its shareholders with a Corporate Update. Since Pivot's entry into the cannabis industry, we have accumulated the following four patented or proprietary technologies to deliver cannabinoids into...

2018-01-17 4:00 AM EST

Pivot To Initiate Topical Product Development With Israel Based Research Organizations

Vancouver, British Columbia--(Newsfile Corp. - January 9, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), are pleased to announce that the Company has signed a Service Agreement with SoluBest Ltd., an Israeli-based research organization that specializes in the development of client tailored formulation and pilot production...

2018-01-09 7:00 AM EST

Pivot to Commercialize Cannabis Products in California Under New Regulations

Vancouver, British Columbia--(Newsfile Corp. - January 3, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce that its recent Binding Letter of Intent to acquire ERS Holdings LLC's patent for Ready To Infuse Cannabis Technology (RTIC) for food and beverage-based products will permit the company to commercialize K-Cup and Stick Pack cannabis products under the new regulations that took effect in California on January 1st, 2018. Pivot...

2018-01-03 4:00 AM EST

Pivot Enters Into Standstill Agreement

Vancouver, British Columbia--(Newsfile Corp. - December 27, 2017) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") wishes to announce that it has entered into a forty-five (45) day standstill period with a TSX listed company in order to explore a business opportunity of mutual interest and benefit, that may result in a co-research and development program, a product launch and/or commercialization agreement, or some other form of potential partnership...

2017-12-27 4:00 AM EST

Pivot to Enter Legal Cannabis Markets in U.S.

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), are pleased to announce that Pivot has signed a binding letter of intent to establish a California-based entity ("PGS-California") in order to accelerate the monetization of the Ready To Infuse Cannabis ("RTIC")...

2017-12-22 9:25 AM EST

Pivot Pharma Signs Binding Letter of Intent to Acquire Cannabis Oil Infusion Technology for Use in Food and Beverage Products

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2017) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biopharmaceutical company, is pleased to announce that the Company has signed a Binding Letter of Intent to acquire ERS Holdings, LLC ("ERS"), a privately-held California company. ERS has developed a patented technology called "RTIC" - Ready To Infuse Cannabis ("the Patent") and has also filed several continuation patents relating to...

2017-12-20 4:00 AM EST

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us